Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
ANVSAnnovis Bio(ANVS) Newsfilter·2024-08-06 20:30

PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of Alzheimer's disease globally. The higher incidence of this neurodegenerative disorder has significantly elevated the demand for therapeutic solutions. Alzheimer's is characterized as a chronic brain condition that frequently results in dementia, particularly in older individuals. It adversely affects memory, cogn ...